Journal
BLOOD TRANSFUSION
Volume 14, Issue 3, Pages 245-254Publisher
SIMTI SERVIZI SRL
DOI: 10.2450/2015.0099-15
Keywords
muscle injuries; haematoma; tennis leg; platelet-rich plasma; growth factors
Categories
Funding
- Instituto de Salud Carlos III, Spain [PI080724]
- Fondo de Investigacion Sanitaria, Spain
Ask authors/readers for more resources
Background. The goals of the treatment of muscle injuries are to shorten the time of healing and to avoid relapses. The aim of this study was to assess the efficacy of autologous platelet-rich plasma (PRP) in the healing of muscle injuries. Materials and methods. A multicentre, randomised, double-blind, parallel, controlled clinical trial was conducted in 71 patients (81.8% males) aged 45.6 (SD=10.0) years with muscle tears in the legs and haematoma. The haematoma was evacuated in all patients. Thirty-three patients were randomised to a single dose of autologous PRP and 38 patients to simulation of PRP administration. The primary end-point was time to complete recovery of muscle injury. Secondary end-points were pain, relapses, ultrasound parameters, and adverse events. The total follow-up per patient was 12 months. Results. Time to complete recovery after the treatment was 31.63 days (SD=15.38) in the PRP group, and 38.43 days (SD=18.58) in the control group (p=0.261). Pain decreased over time in both groups without statistical differences between them. Eight patients relapsed (seven in the control group, and one in the PRP group). There were no adverse effects related to the interventions. Discussion. Autologous PRP did not significantly improve the time to healing compared to that in the control group.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available